These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4647834)

  • 1. A new Micromonospora-produced macrolide antibiotic, rosamicin.
    Wagman GH; Waitz JA; Marquez J; Murawaski A; Oden EM; Testa RT; Weinstein MJ
    J Antibiot (Tokyo); 1972 Nov; 25(11):641-6. PubMed ID: 4647834
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic.
    Waitz JA; Drube CG; Moss EL; Weinstein MJ
    J Antibiot (Tokyo); 1972 Nov; 25(11):647-52. PubMed ID: 4486485
    [No Abstract]   [Full Text] [Related]  

  • 3. Megalomicin, a new macrolide antibiotic complex produced by Micromonospora.
    Weinstein MJ; Wagman GH; Marquez JA; Testa RT; Oden E; Waitz JA
    J Antibiot (Tokyo); 1969 Jun; 22(6):253-8. PubMed ID: 5810991
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrolide antibiotics M-4365 produced by Micromonospora. III. In vitro antimicrobial activity of antibiotic M-4365G2 (de-epoxy rosamicin).
    Yamaguchi T; Hayasaka H; Yoshida H; Matsushita T; Yamabe A; Ohshima S
    J Antibiot (Tokyo); 1978 May; 31(5):433-40. PubMed ID: 27495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin.
    Crowe CC; Sanders WE
    Antimicrob Agents Chemother; 1974 Mar; 5(3):272-5. PubMed ID: 4840436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on a new antibiotic M-92 produced by Micromonospora. III. Biological activities.
    Tani K; Arai Y; Yamaguchi T
    J Antibiot (Tokyo); 1982 Nov; 35(11):1441-7. PubMed ID: 7161183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide antibiotics M-4365 produced by Micromonospora. IV. Antimycoplasmal activity of antibiotic M-4365 G2 (de-epoxy rosamicin).
    Onta T; Maezawa I; Kinumaki A; Ohshima S; Yamaguchi T
    J Antibiot (Tokyo); 1981 Jun; 34(6):719-26. PubMed ID: 7275854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maridomycin, a new macrolide antibiotic. 3. In vitro and in vivo antibacterial activity.
    Kondo M; Oishi T; Ishifuji K; Tsuchiya K
    J Antibiot (Tokyo); 1973 Apr; 26(4):206-14. PubMed ID: 4782049
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation and characterization of 23-O-mycinosyl-20-dihydro-rosamicin: a new rosamicin analogue derived from engineered Micromonospora rosaria.
    Anzai Y; Sakai A; Li W; Iizaka Y; Koike K; Kinoshita K; Kato F
    J Antibiot (Tokyo); 2010 Jun; 63(6):325-8. PubMed ID: 20414322
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological activity of megalomicin, a new Micromonospora-produced macrolide antibiotic complex.
    Waitz JA; Moss EL; Oden EM; Weinstein MJ
    J Antibiot (Tokyo); 1969 Jun; 22(6):265-72. PubMed ID: 4390258
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolypomycin, a new antibiotic. V. In vitro and in vivo antimicrobial activity.
    Kondo M; Oishi T; Tsuchiya K
    J Antibiot (Tokyo); 1972 Jan; 25(1):16-24. PubMed ID: 4110839
    [No Abstract]   [Full Text] [Related]  

  • 12. Preliminary studies on megalomicin, a new Micromonospora-produced macrolide antibiotic complex.
    Weinstein MJ; Wagman GH; Marquez J; Oden E; Testa RT; Waitz JA
    Antimicrob Agents Chemother (Bethesda); 1968; 8():260-1. PubMed ID: 5735370
    [No Abstract]   [Full Text] [Related]  

  • 13. A new antibiotic XK-62-2 (Sagamicin). I. Isolation, physicochemical and antibacterial properties.
    Okachi R; Kawamoto I; Takasawa S; Yamamoto M; Sato S
    J Antibiot (Tokyo); 1974 Oct; 27(10):793-800. PubMed ID: 4457527
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotic AB-65, a new antibiotic from Saccharomonospora viride.
    Tamura A; Takeda I
    J Antibiot (Tokyo); 1975 May; 28(5):395-7. PubMed ID: 1165224
    [No Abstract]   [Full Text] [Related]  

  • 15. The susceptibility of anaerobic bacteria to rosamicin, erythromycin and clindamycin and factors affecting the activity of rosamicin.
    Kwok YY; Sutter VL; Oberhammer I; Finegold SM
    J Antimicrob Chemother; 1979 Jan; 5(1):61-6. PubMed ID: 33142
    [No Abstract]   [Full Text] [Related]  

  • 16. New antibiotic produced by Micromonospora globosa.
    Shiomi K; Iinuma H; Naganawa H; Hamada M; Hattori S; Nakamura H; Takeuchi T; Iitaka Y
    J Antibiot (Tokyo); 1990 Aug; 43(8):1000-5. PubMed ID: 2211346
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic 6640, a new Micromonospora-produced aminoglycoside antibiotic.
    Weinstein MJ; Marquez JA; Testa RT; Wagman GH; Oden EM; Waitz JA
    J Antibiot (Tokyo); 1970 Nov; 23(11):551-4. PubMed ID: 5487129
    [No Abstract]   [Full Text] [Related]  

  • 18. Sulfomycins, a series of new sulfur-containing antibiotics. I. Isolation, purification and properties.
    Egawa Y; Umino K; Tamura Y; Shimizu M; Kaneko K
    J Antibiot (Tokyo); 1969 Jan; 22(1):12-7. PubMed ID: 4305864
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation, purification and preliminary characterization of megalomicin.
    Marquez J; Murawski A; Wagman GH; Jaret RS; Reimann H
    J Antibiot (Tokyo); 1969 Jun; 22(6):259-64. PubMed ID: 5810992
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics.
    Niitu Y; Hasegawa S; Suetake T; Kubota H; Komatsu S; Horikawa M
    J Pediatr; 1970 Mar; 76(3):438-43. PubMed ID: 5413664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.